We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > antibody-drug

News List

WuXi XDC and LegoChem Biosciences Signed Memorandum of Understanding for the Development and Manufacturing of Antibody-drug Conjugates firstwordpharma
June 10, 2021
WuXi XDC today announced that a Memorandum of Understanding (MOU) was signed to form a strategic partnership in development and manufacturing of antibody-drug conjugates (ADCs).
Byondis Initiates Phase I Study of Antibody-Drug Conjugate SYD1875 b3cnewswire
August 22, 2020
Byondis B.V. (formerly Synthon Biopharmaceuticals B.V.) today announced that the first cancer patients have started treatment with its investigational antibody-drug conjugate (ADC) SYD1875.
MilliporeSigma Collaborates with Angiex to Speed Clinical Readiness of New Cancer Therapy americanpharmaceuticalreview
August 30, 2017
MilliporeSigma is supporting Angiex's ability to speed its lead oncology antibody drug candidate to clinical use.